ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 173 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2019. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,391,975 | +233.0% | 33,868 | +235.8% | 0.12% | +24.2% |
Q3 2022 | $418,000 | -24.0% | 10,086 | +33.1% | 0.10% | -35.8% |
Q1 2022 | $550,000 | +67.7% | 7,580 | +94.4% | 0.15% | +32.1% |
Q4 2021 | $328,000 | +11.9% | 3,900 | +20.0% | 0.11% | +17.9% |
Q3 2021 | $293,000 | +20.6% | 3,250 | +27.5% | 0.10% | -5.0% |
Q2 2021 | $243,000 | -40.7% | 2,550 | -29.2% | 0.10% | -60.3% |
Q1 2021 | $410,000 | -27.7% | 3,600 | -72.8% | 0.25% | +17.8% |
Q3 2019 | $567,000 | +34.0% | 13,244 | +50.7% | 0.21% | -48.7% |
Q4 2018 | $423,000 | – | 8,790 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |